No Data
No Data
Moderna Facing Headwinds for Respiratory Syncytial Virus, COVID Vaccines, RBC Says
Unusual Options Activity: PFE, PAYC and Others Attract Market Bets, PFE V/OI Ratio Reaches 217.6
Trending Industry Today: Altimmune Leads Losses Pre-Market In Weight Loss Drugs Stocks
With 68% Ownership of the Shares, Pfizer Inc. (NYSE:PFE) Is Heavily Dominated by Institutional Owners
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Express News | BioNTech SE - Q2 Revenue at 128.7 Mln EUR